Status:
COMPLETED
Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)
Eligibility:
All Genders
Brief Summary
This clinical trial studies genetic biomarkers from saliva samples in patients with Ewing sarcoma. Studying samples of saliva from patients with cancer in the laboratory may help doctors learn more ab...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the association between the length of Ewing sarcoma breakpoint region 1-Friend leukemia virus integration 1 (EWS-FLI1) fusion protein binding sites (microsatellite...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The patient is enrolled on ACCRN07
- The patient has a diagnosis of Ewing Sarcoma (International Classification of Diseases \[ICD\] code morphology 9260; topography C40.0-C41.9, C76.0-C76.8, C80.9) and is registered with Children's Oncology Group (COG) by a North American member institution
- The patient must be diagnosed with Ewing sarcoma between December 24, 2007 and December 31, 2015
- The patient must have at least one biological parent alive and willing to participate
- All questionnaire respondents must understand English or Spanish
- Concomitant treatment on a therapeutic trial is not required
Exclusion
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT01876303
Start Date
December 1 2012
Last Update
July 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Monrovia, California, United States, 91006-3776